The effectiveness of nurse- and pharmacist-directed care in diabetes disease management: A narrative review

Current Diabetes Reviews

Volumn 3, Issue 4, 2007, Pages 280-286

  Davidson, Mayer B ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Diabetes disease management; Nurse and pharmacist directed diabetes care; Quality of diabetes care

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL;

ADD ON THERAPY; CARDIOVASCULAR DISEASE; CASE MANAGEMENT; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONSULTATION; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DOCTOR PATIENT RELATION; EVIDENCE BASED MEDICINE; FEEDBACK SYSTEM; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; LASER COAGULATION; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; MONOTHERAPY; MORBIDITY; MORTALITY; NARRATIVE; NURSE PATIENT RELATIONSHIP; NURSING CARE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SCHEDULING; PHARMACIST; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REVIEW; SMOKING CESSATION; STROKE; UNITED STATES;

DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; NURSES; PHARMACISTS; PRACTICE GUIDELINES AS TOPIC; QUALITY ASSURANCE, HEALTH CARE;

EID: 36148937517     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339907782330058     Document Type: Review

References (109)

1. Klein R, Klein BEK. Vision disorders in diabetes. In: Diabetes in America, Eds: National Diabetes Data Group, 2nd Edition, NIH Publication No. 95-1468, 1995; pp 293-339.
2. Nelson RG, Knowler WC, Pettit DJ, Bennett PH. Kidney diseases in diabetes. In: Diabetes in America, Eds: National Diabetes Data Group, 2nd Edition, NIH Publication No, 95-1468, 1995; pp. 349-400.
3. Habershaw G. Foot lesions in patients with diabetes: cause, prevention, and treatment. In: Joslin's Diabetes Mellitus, Eds: Kahn CR, Weir GC, 13th edition, 1994; pp 962-9.
4. Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. In: Diabetes in America, Eds: National Diabetes Data Group, 2nd Edition, NIH Publication No. 95-1468, 1995; pp 409-28.
5. Rubin RJ, Altman WM, Mendelson DN. Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 1994; 78: 809A-809F.
6. Wingard DL, Barrett-Connor E. Heart disease and diabetes. In: Diabetes in America, Eds: National Diabetes Data Group, 2nd Edition, NIH Publication No. 95-1468, 1995; pp 429-48.
7. Koller LH. Stroke and diabetes. In: Diabetes in America, Eds: National Diabetes Data Group, 2nd Edition, NIH Publication No. 95-1468, 1995; pp 449-56.
8. Palumbo PJ, Melton III LJ. Peripheral vascular disease and diabetes. In: Diabetes in America, Eds: National Diabetes Data Group, 2nd Edition, NIH Publication No. 95-1468, 1995; pp 401-8.
9. Skyler JS. Diabetic complications: the importance of control. Endocrinol Metab Clin North Am 1996; 25: 243-254.
10. Krolewski AS, Laffel LMB, Krolewski M, et al. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995; 332: 1251-5.
11. Warram JH, Scott LJ, Hanna LS, et al. Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia. Diabetes 2000; 49: 94-100.
12. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-17.
13. Tanaka Y, Atsumi Y, Matsuoka K, et al. Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients. Diabetes Care 1998; 21: 116-20.
14. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet 2005; 366: 1267-78.
15. Fuller J, Stevens LK, Chaturvedi N, et al. Antihypertensive therapy for preventing cardiovascular complications in people with diabetes and systolic hypertension. Cochrane Database Syst Rev 2000(2): CD002188 [PMID: 10796872].
16. Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension: Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996; 276: 1886-92.
17. Tuomilehto J, Rastenyte D, Birkenhager WH, et al. Effects of calcium channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999; 340: 677-84.
18. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood pressure lowering and low-dose aspirin on patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998; 351: 1755-62.
19. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complicatiotis in type 2 diabetes. UKPDS 38. BMJ 1998; 317: 703-13.
20. Estacio RO, Jeffers BW, Gifford N, et al. Effect of blood pressure control on diabetic microvascular complications in patients with-hypertension and type 2 diabetes. Diabetes Care 2000; 23 (Suppl 2): B54-B64.
21. Ravid M, Savin H, Jutrin I, et al. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118: 577-81.
22. Viberti G, Mogensen CE, Groop LC, Pauls JF, for the European Microalbuminuria Captopril Study Group. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microal-buminuria. JAMA 1994; 271: 275-9.
23. Ravid M, Lang R, Rachmani R, Lishner M. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: a 7-year follow-up study. Arch Intern Med 1996; 156: 286-9.
24. Laffel LMB, McGill JB, Gans DJ, on the behalf of the North American Microalbuminuria Study Group. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. Am J Med 1995; 99: 497-504.
25. The Microalbuminuria Captopril Study Group. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. Diabetologia 1996; 39: 587-93.
26. The EUCLID Study Group. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997; 349: 1787-92.
27. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. New Engl J Med 1993; 329: 1456-62.
28. The Diabetic Retinopathy Study Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of diabetic retinopathy study (DRS) findings. DRS report number 8. Ophthalmology 1981; 88: 583-600.
29. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema; early treatment diabetic retinopathy study report number 1. Arch Ophthalmol 1985; 103: 1796-806.
30. Collaborative overview of randomised trials of antiplatelet therapy-1: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialist' Collaboration. BMJ 1994; 308: 81-106.
31. Final report on the aspirin component of the ongoing Physicians' Health Study Research Group. New Engl J Med 1999; 321: 129-35.
32. The ETDRS Investigators. Aspirin effects on mortality and morbidity in patients with diabetes mellitus: Early Treatment Diabetic Retinopathy Study report 14. JAMA 1992; 268: 1292-1300.
33. American Diabetes Association. Standards of Medical Care in Diabetes-2007. Diabetes Care 2007; 30 (Suppl 1): S4-S41.
34. McGinn J, Davis C. Geographic variation, physician characteristics, and diabetes care disparities in a metropolitan area. Diabetes Res Clin Pract 2006; 72: 162-9.
35. Ackermann RT, Thompson TJ, Selby JV, et al. Is the number of documented diabetes process-of-care indicators associated with cardiometabloic risk factor levels, patient satisfaction, or self-related quality of diabetes care? The Translating Research into Action for Diabetes (TRIAD) study. Diabetes Care 2006; 29: 2108-13.
36. Mangione CM, Gerzoff RB, Williamson DF, et al. The association between quality of care and the intensity of diabetes disease management programs. Ann Intern Med 2006; 145: 107-16.
37. Davidson MB. Diabetes care in health maintenance organisation and fee-for-service settings. Dis Manage Health Outcomes 1997; 2: 189-97.
38. Davidson MB. The case for "outsourcing" diabetes care, Diabetes Care 2003; 26: 1608-12.
39. Saydeh SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004; 291: 335-42.
40. Suwattee P, Lynch JC, Pendergrass ML. Quality of care for diabetic patients in a large urban public hospital. Diabetes Care 2003; 26: 563-8.
41. Jacobs MJ, Kleisli T, Malik S, L'italien GJ, Chen RS, Wong ND. Diabetes Res Clin Pract 2005; 70: 263-9.
42. Grant RW, Buse JB, Meigs JB, et al. Quality of diabetes care in U. S. academic medical centers. Diabetes Care 2005; 28: 337-42.
43. Beaton SJ, Nag SS, Gunter MJ, Gleeson JM, Sajjan SS, Alexander CM. Adequacy of glycemic, lipid, and blood pressure management of patients with diabetes in a managed care setting. Diabetes Care 2004; 27: 694-8.
44. McFarlene SI, Jacober SJ, Winer N, et al. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care 2002; 25: 718-23.
45. Kemp TM, Barr ELM, Zimmer PZ, et al. on behalf of the AusDiab Committee. Glucose, lipid, and blood pressure control in Australian adults with type 2 diabetes: the 1999-2000 AusDiab. Diabetes Care 2005; 28: 1490-2.
46. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Venkat Narayan KM. A diabetes report card for the United States: quality of care in the 1990's. Ann Intern Med 2002; 136: 565-74.
47. Chin MH, Zhang HX, Merrell K. Diabetes in the African-American medicare population: morbidity, quality of care, and resource utilization. Diabetes Care 1998; 21: 1090-5.
48. Greenfield S, Kaplan SH, Kahn R, Ninomiya J, Griffith JL. Profiling care by different groups of physicians: effects of patient case-mix (bias) and physician-level clustering on quality assessment results. Ann Intern Med 2002; 136: 111-21.
49. Grant RW, Cagliero E, Murphy-Sheehy P, et al. Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes. Am J Med 2002; 112: 603-9.
50. Acton KJ. Shields R, Rith-Najarian S, et al. Applying the diabetes quality improvement project indicators in the Indian Health Service primary care setting. Diabetes Care 2001; 24: 22-6.
51. Srinivasan M, Przyblski M, Swigonski N. The Oregon Health Plan: predictors of office-based diabetic quality of care. Diabetes Care 2001; 24: 262-7.
52. Porterfield DS, Kinsinger L. Quality of care for uninsured patients with diabetes in a rural area. Diabetes Care 2002; 25: 319-23.
53. Petitti DB, Contreras R, Ziel FH, Dudl J, Domurat ES, Hyatt JA. Evaluation of the effect of performance monitoring and feedback on care process, utilization, und outcome. Diabetes Care 2000; 23: 192-6.
54. Demakis JG, Beauchamp C, Cull WL, et al. for the Department of Veterans Affairs Cooperative Study Group on Computer Reminders in Ambulatory Care. Improving residents' compliance with standards of ambulatory care: results from the VA Cooperative Study on Computerized Reminders. JAMA 2000; 284: 1411-6.
55. Piette JD, Weinberger M, McPhee SJ, Mah CA, Kraemer FB, Crapo LM. Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? Am J Med 2000; 108: 20-7.
56. Shandro MT, Pick ME, Gruninger A, Ryan EA. Diabetes care: interventions in the community. Diabetes Care 2002; 25: 941.
57. Lobach DF, Hammond WE. Computerized decision support based on a clinical practice guideline improves compliance with care standards. Am J Med 1997; 102: 89-98.
58. 1C after a physician education project. Diabetes Care 1999; 22: 1612-6.
59. de Sonnaville JJJ, Bouma M, Colly LP, Deville W, Wijkel D, Heine RJ. Sustained good glycaemic control in NIDDM pateitns by implementation of structured care in general practice: 2-year follow-up study. Diabetologia 1997; 40: 1334-40.
60. Ilag LL, Martin CL, Tabei BP, et al. Improving diabetes processes of care in managed care. Diabetes Care 2003; 26: 2722-7.
61. Meigs JB, Cagliero E, Dubey A, et al. A controlled tirial of web-based diabetes disease management: the MGH Diabetes Primary Care Improvement Project. Diabetes Care 2003; 26: 750-7.
62. Grant RW, Cagliero, E, Sullivan CM, et al. A controlled trial of population management; diabetes mellitus: putting evidence into practice (DM-PEP). Diabetes Care 2004; 27: 2299-305.
63. Ziemer DC, Doyle JP, Barnes CS, et al. An intervention to overcome clinica inertia and improve diabetes mellitus control in a primary care setting: improving pprimary care of African Americans with diabetes (IPCAAD) 8. Arch Intern Med 2006; 166: 507-13.
64. Weinberger M, Kirkman S, Samsa GP, et al. A nurse-coordinated intervention for primary care patients with non-insulin-dependnet diabetes mellitus: impact on glycemic control and health-related quality of life. J Gen Intern Med 1995; 10: 59-66.
65. Piette JD, Weinberger MD, Kraemer FB, McPhee SJ. Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System; a randomized controlled trial. Diabetes Care 2001; 24: 202-8.
66. Gary TL, Bone LR, Hill MN, et al. Randomized controlled trial of the effects of nurse manager and community health worker interventions on risk factors for diabetes-related complications in urban African Americans. Prev Med 2003; 37: 23-32.
67. Krein SL, Klamerus ML, Vijan S, et al. Case management for patients with poorly controlled diabetes: a randomized trial. Am J Med 2004; 116: 732-9.
68. Wolf AM, Conaway MR, Crowther JQ, Hazen KY. Translating lifestyle intervention to practice in obese patients with type 2 diabetes: improving control with activity and nutrition (ICAN). Diabetes Care 2004; 27: 1570-6.
69. Shane-McWhorter L, Oderda GM. Providing diabetes education and care to underserved patients in a collaborative practice at a Utah community health center. Pharmcotherapy 2005; 25: 96-109.
70. Glasgow RE, Nutting PA, King DK, et al. Randomized effectiveness trial of a computer-assisted intervention to improve diabetes care. Diabetes Care 2005; 28: 33-9.
71. Gabbay RA, Lendel I, Saleem TM, et al. Nurse case management improves blood pressure, emotional distress and diabetes complication screening. Diabetes Res Clin Pract 2006; 71: 28-35.
72. Kirkman MS, Williams SR, Caffrey RA, Marrero DG. Impact of a program to improve adherence to diabetes guidelines by primary care physicians. Diabetes Care 2002; 25: 1946-51.
73. Hirsch IB, Goldberg HI, Ellsworth A, et al. A multifaceted intervention in support of diabetes treatment guidelines: a controlled trial. Diabetes Res Clin Pract 2002; 58: 27-36.
74. Majumdar SR, Guirguis LM, Toth EL, Lewanczuk RZ, Lee TK, Johnson JA. Controlled trial of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes. Diabetes Care 2003; 26: 3061-6.
75. Chin MH, Cook S, Drum ML, et al. Improving diabetes care in Midwest community health centers with the health disparities collaborative. Diabetes Care 2004; 27: 2-8.
76. Johnson JA, Eurich DT, Toth EL, Lewanczuk RZ, Lee TK, Majumdar SR. Generalizability and persistence of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes. Diabetes Care 2005; 28: 783-8.
77. O'Connor PJ, Desai J, Sollberg LI, et al. Randomized trial of quality improvement intervention in improve diabetes care in primary care settings. Diabetes Care 2005; 28: 1890-7.
78. Benjamin EM, Schneider MS, Hinchey KT. Implementing practice guidelines for diabetes care using problem-based learning: a prospective controlled trial using firm systems. Diabetes Care 1999; 22: 1672-8.
79. Legorreta AP, Peters AL, Ossorio C, Lopez RJ, Jatulis D, Davidson, MB. Effect of a comprehensive nurse-managed diabetes program: an HMO study. Am J Manag Care 1996; 2: 1024-30.
80. Aubert RE. Herman WH, Waters J, et al. Nurse case management to improve glycemic control in diabetic patients in a Health Maintenance Organization: a randomized trial. Ann Intern Med 1998; 129: 605-12.
81. Peters AL, Davidson MB. Application of a diabetes managed care program: the feasibility of using nurses and a computer system to provide effective care. Diabetes Care 1998; 21: 1037-43.
82. Blonde L, Guthrie RD, Testa MA, et al. Diabetes Management by a team of diabetes nurse educators, endocrinologists and priimary care physicians in a managed care environment. Diabetes 1999; 48 (Suppl 1): 198A.
83. Thompson DT, Kozak SE, Sheps S. Insulin adjustment by a diabetes nurse educator improves glucose control in insulin-requiring diabetic patients: a randomized trial. CMAJ 1999; 161: 959-62.
84. 1C: Am J Manag Care 2000; 6: 1217-26.
85. Davidson MB. Effect of nurse-directed diabetes care in a minority population. Diabetes Care 2003; 26: 2281-7.
86. Polansky WH, Earles J, Smith S, et al. Integrating medical management with diabetes self-management training; a randomized control trial of the Diabetes Outpatient Intensive Treatment program. Diabetes Care 2003; 26: 3048-53.
87. Taylor CB, Miller NH, Reilly KR, et al. Evaluation of a nurse care management system to improve outcomes in patients with complicated diabetes. Diabetes Care 2003; 26: 1058-63.
88. Kim H-S, Oh J-A. Adherence to diabetes control recommendations; impact of nurse telephone calls. J Adv Nursing 2003; 44: 256-61.
89. Philis-Tsimikas A, Walker C, Rivard L, et al. Improvements in diabetes care of underinsured patients enrolled-in Project Dulce: a community-based, culturally appropriate, nurse case management and peer education diabetes care model. Diabetes Care 2004; 27: 110-5.
90. Fanning EL, Selwyn BJ, Larme AC, DeFronzo RA. Improving efficacy of diabetes management using treatment algorithms in a mainly Hispanic population. Diabetes Care 2004; 27: 1638-46.
91. The California Medi-Cal Type 2 Diabetes Study Group Closing the gap: effect of diabetes case management on glycemic control among low-income ethnic minority populations. Diabetes Care 2004; 27: 95-103.
92. Davidson MB, Castellanos M, Duran P, Karlan V. Effective diabetes disease management for a poor and poorly educated minority population. Am J Manag Care 2006; 12: 226-32.
93. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996; 30: 238-43.
94. Davidson MB, Karlan VJ, Hair TL. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual 2000; 15: 137-42.
95. Nowak SN, Singh R, Clarke A, Campbell E, Jaber LA. Metabolic control and adherence to American Diabetes Association practice guidelines in a pharmacist-managed diabetes clinic. Diabetes Care 2002; 25: 1479.
96. Rothman RL, Malone R, Bryant B, et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005; 118: 276-84.
97. Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S. Proactive case managemend of high-risk patients with type 2 diabetes by a clinical pharmacist: a randomized controlled trial. Am J Manag Care 2005; 41: 253-60.
98. Clark CM, Snyder JW, Meek RL, Stutz LM, Parkin CG. A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction. Diabetes Care 2001; 24: 1079-1086.
99. Peters AL, Young RT, Knight KK, Porter MH. Improvements in glycemic control with a care manager-based diabetes control program. Diabetes 1999; 48 (Suppl 1): A197-8.
100. Leal S, Glover JJ, Herrier RN, Felix A. Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care 2004; 27: 2893-4.
101. Shane-McWhorter L. Diabetes care in community health centers: a focus on health resources and services administration-funded clinical pharmacy demonstration projects. Diabetes Spectr 2006; 19: 141-4.
102. Pettit OJ, Wollitzer AO, Jovanovic, L, He G, Ipp E, the California Medi-Cal Type 2 Diaketes Study Group. Decreasing the risk of diabetic retinopathy in a study of case management: the California Medi-Cal Type 2 Diabetes Study. Diabetes Care 2005; 28: 2819-22.
103. Gilmer TP, Roze S, Valentine WJ, et al. Cost-effectiveness of diabetes case management for low-income populations. Health Research and Educational Trust 2007; DOI: 10,1111/j.1475-6773.2007.0071.x.
104. Shojania KG, Ranji SR, McDonald KM, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 2006; 296: 427-40.
105. Wetzler P, Snyder JW. Linking pharmacy and laboratory data to assess the appropriateness of care in patients with diabetes. Diabetes Care 2000; 23: 1637-41.
106. Brown JB, Nichols GA. Slow response to loss of glycemic control in type 2 diabetes mellitus. Am J Manag Care 2003; 9: 213-7.
107. Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care 2004; 27: 1535-40.
108. Shan BR, Hux JE, Laupacis A, Zinman B, van Walraven C. Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care 2005; 28: 600-6.
109. Venkat Narayan KM, Boyle JP, Geiss LS, Saddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 2006; 29: 2114-6.